These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 17229513

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG, Cheema P, Gelbaya TA, Horne G, Fitzgerald CT, Pease EH, Brison DR, Lieberman BA.
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of coasting on IVF cycle characteristics and outcome in short vs. long GnRH agonist protocols.
    Farhi J, Fisch B, Sapir O, Pinkas H, Ben-Haroush A.
    Gynecol Endocrinol; 2010 Mar; 26(3):187-92. PubMed ID: 20148740
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].
    Kdous M, Chaker A, Zhioua A, Zhioua F.
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):133-43. PubMed ID: 19179017
    [Abstract] [Full Text] [Related]

  • 10. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A.
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [Abstract] [Full Text] [Related]

  • 11. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer].
    Ma QH, Li SW, Huang ZY, Han ZY, Qiu DS, Han DW.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
    Chen SL, Sun L, Kong LH, Li L, Li J, Zhu L, Gao TM, Xing FQ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
    Ho Yuen B, Nguyen TA, Cheung AP, Leung PC.
    Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles.
    Owj M, Tehrani-Nejad ES, Amirchaghmaghi E, Baghestani AR, Ahmadi J.
    Saudi Med J; 2005 Oct; 26(10):1584-7. PubMed ID: 16228060
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.